SCHEMBL61998

SCHEMBL61998

CCCCCCCC/C=C\CCCCCCCC(=O)OC(C)C

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.79
PRKCA P17252 2/20 0.62
PRKCE Q02156 1/20 0.62
PRKCQ Q04759 1/20 0.62
PRKCD Q05655 1/20 0.62
FAAH O00519 3/20 0.59
MAPT P10636 3/20 0.59
ALDH1A1 P00352 1/20 0.59
HPGD P15428 1/20 0.59
CNR1 P21554 1/20 0.59
CNR2 P34972 1/20 0.59
TERT O14746 3/20 0.58
PTPN1 P18031 3/20 0.58
PPARG P37231 3/20 0.58
PPARD Q03181 3/20 0.58
PPARA Q07869 3/20 0.58
CYP1A2 P05177 2/20 0.58
CYP2C19 P33261 2/20 0.58
BLM P54132 2/20 0.58
HSD17B10 Q99714 2/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL80898 1.00 LMNA (0.79) LMNAPRKCAPRKCEPRKCQPRKCD
SCHEMBL10338455 1.00 LMNA (0.79) LMNAPRKCAPRKCEPRKCQPRKCD
SCHEMBL18133442 1.00 LMNA (0.79) LMNAPRKCAPRKCEPRKCQPRKCD
SCHEMBL10338452 1.00 LMNA (0.79) LMNAPRKCAPRKCEPRKCQPRKCD
SCHEMBL6514796 1.00 LMNA (0.79) LMNAPRKCAPRKCEPRKCQPRKCD
SCHEMBL3656513 1.00 LMNA (0.79) LMNAPRKCAPRKCEPRKCQPRKCD
SCHEMBL6514791 1.00 LMNA (0.79) LMNAPRKCAPRKCEPRKCQPRKCD
SCHEMBL6429415 1.00 LMNA (0.79) LMNAPRKCAPRKCEPRKCQPRKCD
SCHEMBL4124375 1.00 LMNA (0.79) LMNAPRKCAPRKCEPRKCQPRKCD
SCHEMBL28578863 1.00 LMNA (0.79) LMNAPRKCAPRKCEPRKCQPRKCD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 4189 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3883534-B1 OILY FACIAL CARE PREPARATION BEIERSDORF AG (DE) 2026-05-06 EP claimed
US-12605325-B2 Hair styling compositions for improving the elongation of hair curls L'OREAL (FR) 2026-04-21 US claimed
US-20260096969-A1 Compositions Containing a UV-Absorbing System Including Physical UV-Attenuating Material, Trihydroxystearin and Fatty Acid Oil For Inhibiting Trihydroxystearin Crystallization L'OREAL (FR) 2026-04-09 US claimed
EP-4713412-A1 HEAT TRANSFER FLUIDS FOR ELECTRIC VEHICLES Prestone Products Corporation (US) 2026-03-25 EP claimed
EP-4646183-A1 COSMETIC EMULSION WITH DIISOPROPYL ADIPATE AND POLYGLYCERYLESTER Beiersdorf AG (DE) 2025-11-12 EP claimed
EP-4034069-B1 HAIR COSMETIC COMPOSITIONS CONTAINING GUMS FATTY ALCOHOL, AND ESTERS OREAL (FR) 2025-10-01 EP claimed
EP-4065237-B1 A CONDITIONING COMPOSITION BEIERSDORF AG (DE) 2025-09-24 EP claimed
EP-4065071-B1 A CONDITIONING COMPOSITION BEIERSDORF AG (DE) 2025-09-17 EP claimed
CN-119970641-A Nonaqueous preparation with controllable release behavior and application thereof 中国科学院上海药物研究所 2025-05-13 CN claimed
CN-119973099-A Magnetic powder modifier, preparation method and application thereof, and production method of neodymium-iron-boron magnet 包头稀土研究院 2025-05-13 CN claimed
WO-1995000107-A1 SKIN AND SCALP BARRIER FOR USE WITH HAIR TREATMENT PRODUCTS AMINCO, INC. (US) 1995-01-05 WO claimed
WO-1994006401-A1 MOISTURIZING LIPSTICK COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 1994-03-31 WO claimed
EP-0511652-A1 Hair shampoo composition to impart improved hair conditioning properties HELENE CURTIS, INC. (US) 1992-11-04 EP claimed
EP-0235259-B1 NOVEL TRANSDERMAL ANTI-ANGINAL PHARMACEUTICAL DOSAGE UNIT AND PROCESS FOR ITS ADMINISTRATION RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 1992-07-29 EP claimed
EP-0334956-A1 HEMOLYSIS INHIBITOR AND MEDICAL RESIN COMPOSITION, MEDICAL IMPLEMENT, AND BLOOD-PRESERVING FLUID CONTAINING THE SAME Kao Corporation (JP) 1989-10-04 EP claimed
EP-0235259-A4 NOVEL TRANSDERMAL ANTI-ANGINAL PHARMACEUTICAL DOSAGE UNIT AND PROCESS FOR ITS ADMINISTRATION. UNIV RUTGERS (US) 1988-10-20 EP claimed
EP-0235259-A1 NOVEL TRANSDERMAL ANTI-ANGINAL PHARMACEUTICAL DOSAGE UNIT AND PROCESS FOR ITS ADMINISTRATION. UNIV RUTGERS (US) 1987-09-09 EP claimed
EP-0224981-A2 Nitroglycerin transdermal delivery system PACO RESEARCH CORPORATION (US) 1987-06-10 EP claimed
WO-1987001291-A1 NOVEL TRANSDERMAL ANTI-ANGINAL PHARMACEUTICAL DOSAGE UNIT AND PROCESS FOR ITS ADMINISTRATION RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 1987-03-12 WO claimed
US-4364743-A ESTER AND MIDDLE OIL ERNER WILLIAM E 1982-12-21 US claimed